Shu represents technology and life sciences companies in strategic intellectual property and data-driven transactions. She also routinely advises investors and acquirers on the intellectual property and commercial considerations of venture capital financings, mergers and acquisitions.

Shu’s practice spans a broad spectrum of innovative technology sectors, including artificial intelligence, life sciences (biotechnology, pharmaceuticals, medical devices, digital health), cleantech and renewable energy, robotics and autonomous vehicles, SaaS and software, and semiconductors.

Shu specializes in counselling venture-backed emerging growth companies on high-stakes strategic transactions with leading U.S. and international corporations, as well as major research institutes and universities, including strategic partnerships, licensing and development agreements, collaborations, spinoffs, carveouts, and joint ventures.  In addition, Shu has extensive experience advising clients on a wide array of commercial and operational matters, such as manufacturing and supply agreements, OEM/ODM arrangements, clinical trial and CRO/CDMO agreements, distribution and channel partnerships, and customer agreements.

Dawning on her legal training and professional experiences in the U.S., Europe, and China, Shu brings a deep, practical understanding of the global legal, regulatory, and business landscapes, particularly in China, and is uniquely positioned to guide her clients through the complexities of cross-border transactions and help them develop, use, commercialize and protect their innovative assets across jurisdictions.

Prior to joining Gunderson, Shu served as a legal assistant at the World Intellectual Property Organization (WIPO) in Geneva, Switzerland.